Share
Virginia is expected to receive more than half a billion dollars from opioid distributors McKesson, AmerisourceBergen and Cardinal, and opioid manufacturer Johnson & Johnson.
Share
The Treasury Department today released guidance on acceptable uses of American Rescue Plan funds — including to combat the substance abuse epidemic in communities across the country.
Share
A bipartisan effort is calling on the Treasury Department to allow states to use American Rescue Plan funding to combat increases in drug overdose deaths witnessed during the COVID-19 pandemic.
Share
Legislation directing funds from lawsuits against drug manufacturers and distributors to go toward opioid abuse prevention, treatment and recovery is headed to the governor’s desk to be signed into law.
Share
McKinsey & Company has agreed to a $573 million settlement to resolve investigations into the consulting firm’s role in working for opioid companies, helping those companies promote their drugs, and profiting from the opioid epidemic.
Share
A bipartisan coalition of 48 attorneys general in pushing federal regulators to examine recent progress in their fight against opioid abuse.
Share
The House of Representatives today passed H.R. 4812, the Ensuring Compliance Against Drug Diversion Act, introduced by Ninth District Congressman Morgan Griffith.
Share
In a paper published Friday by the Journal of the American Medical Association, Virginia Commonwealth University researchers released data showing an alarming surge in opioid-related overdoses during the COVID-19 pandemic.
Share
Connection 2 Care (C2C) is an innovative collaboration led by Virginia Tech researchers that aims to address the opioid crisis in the Roanoke Valley.
Share
The Controlled Substances Act (CSA) governs much of federal drug policy.
Our content is free to read, but we do have bills to pay. Pitch in and help us keep the community informed.